Ventripoint Diagnostics Ltd (VPT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 61 | 1,294 | 5,186 | 9,269 | 526 |
| Receivables | 251 | 285 | 374 | 197 | 165 |
| TOTAL | $474 | $1,637 | $5,663 | $9,502 | $714 |
| Non-Current Assets | |||||
| PPE Net | 184 | 247 | 313 | 43 | 87 |
| TOTAL | $184 | $247 | $313 | $43 | $87 |
| Total Assets | $658 | $1,883 | $5,977 | $9,545 | $802 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,357 | 60 | 50 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,700 | 949 | 842 | 989 | 1,014 |
| Accrued Expenses | 295 | 301 | 122 | 62 | 766 |
| Other current liabilities | N/A | N/A | N/A | N/A | 1 |
| TOTAL | $3,427 | $1,397 | $1,056 | $1,085 | $1,823 |
| Non-Current Liabilities | |||||
| Long Term Debt | 59 | 78 | 93 | 125 | 1,293 |
| Deferred Revenues | 10 | 32 | N/A | N/A | N/A |
| TOTAL | $212 | $297 | $367 | $125 | $1,327 |
| Total Liabilities | $3,640 | $1,694 | $1,423 | $1,211 | $3,150 |
| Shareholders' Equity | |||||
| Common Shares | 43,777 | 42,675 | 42,675 | 42,214 | 31,009 |
| Retained earnings | -58,413 | -53,493 | -48,621 | -43,748 | -39,867 |
| Other shareholders' equity | 45 | 93 | 78 | 112 | 109 |
| TOTAL | $-2,982 | $190 | $4,554 | $8,334 | $-2,349 |
| Total Liabilities And Equity | $658 | $1,883 | $5,977 | $9,545 | $802 |